Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan

被引:149
作者
Fujimura, Y. [1 ]
Matsumoto, M. [1 ]
Isonishi, A. [1 ]
Yagi, H. [1 ]
Kokame, K. [2 ]
Soejima, K. [3 ]
Murata, M. [4 ]
Miyata, T. [2 ]
机构
[1] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 6348522, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan
[3] Chemoserotherapeut Res Inst, Res Dept 1, Kumamoto, Japan
[4] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan
关键词
ADAMTS13 gene mutation; clinical phenotype; natural history; Upshaw-Schulman syndrome; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC SYNDROME; COLD-INSOLUBLE GLOBULIN; CONGENITAL THROMBOCYTOPENIA; MOLECULAR CHARACTERIZATION; VONWILLEBRAND-FACTOR; P475S POLYMORPHISM; DEFICIENT ACTIVITY;
D O I
10.1111/j.1538-7836.2011.04341.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Upshaw-Schulman syndrome (USS) is an extremely rare hereditary deficiency of ADAMTS13 activity, termed congenital TTP. The clinical signs are usually mild during childhood, often with isolated thrombocytopenia. But their symptoms become more evident when patients have infections or get pregnant. We identified 43 USS-patients in Japan, who ranged in age from early childhood to 79 years of age. Analysing the natural history of these USS patients based on ADAMTS13 gene mutations may help characterise their clinical phenotypes. Severe neonatal jaundice that requires exchange blood transfusion, a hallmark of USS, was found in 18 of 43 patients (42%). During childhood, 25 of 43 patients were correctly diagnosed with USS without gender disparity. These 25 patients were categorised as having ;the early-onset phenotype'. Between 15 and 45 years of age, 15 were correctly diagnosed, and, interestingly, they were all female. The remaining three patients were male and were diagnosed when they were older than 45 years of age, suggesting that they were 'the late-onset phenotype'. Two of these three males developed sudden overt TTP when they were 55 and 63 years old, respectively. These two men had two different homozygous ADAMTS13 gene mutations, p.R193W/p.R193W and p.C1024R/p.C1024R, respectively. Both of which were not discovered in the US or Western countries. In vitro expression studies showed that these two proteins were consistently secreted into the culture medium but to a lesser extent and with reduced activity compared to the wild-type protein. Our results indicate that 'the late-onset phenotype' of USS is formed with ethnic specificity.
引用
收藏
页码:283 / 301
页数:19
相关论文
共 75 条
[1]
ADAMTS13 P475S polymorphism causes a lowered enzymatic activity and urea lability in vitro [J].
Akiyama, M. ;
Kokame, K. ;
Miyata, T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) :1830-1832
[2]
ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[3]
Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency [J].
Assink, K ;
Schiphorst, R ;
Allford, S ;
Karpman, D ;
Etzioni, A ;
Brichard, B ;
van de Kar, N ;
Monnens, L ;
van den Heuvel, L .
KIDNEY INTERNATIONAL, 2003, 63 (06) :1995-1999
[4]
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura [J].
Banno, F ;
Kokame, K ;
Okuda, T ;
Honda, S ;
Miyata, S ;
Kato, H ;
Tomiyama, Y ;
Miyata, T .
BLOOD, 2006, 107 (08) :3161-3166
[5]
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow [J].
Bernardo, A ;
Ball, C ;
Nolasco, L ;
Moake, JF ;
Dong, JF .
BLOOD, 2004, 104 (01) :100-106
[6]
Absence of Pro475Ser polymorphism in ADAMTS-13 in Caucasians [J].
Bongers, TN ;
De Maat, MPM ;
Dippel, DWJ ;
Uitterlinden, AG ;
Leebeek, FWG .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) :805-805
[7]
Cermakova Z, 2009, Prague Med Rep, V110, P239
[8]
DACIE JV, 1953, Q J MED, V22, P79
[9]
In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTSI3 in thrombotic thrombocytopenic purpura [J].
Donadelli, Roberta ;
Banterla, Federica ;
Galbusera, Miriam ;
Capoferri, Cristina ;
Bucchioni, Sara ;
Gastoldi, Sara ;
Nosari, Silvia ;
Monteferrante, Giuseppe ;
Ruggeri, Zaverio M. ;
Bresin, Elena ;
Scheiflinger, Friedrich ;
Rossi, Edoardo ;
Martinez, Constantino ;
Coppo, Rosanna ;
Remuzzi, Giuseppe ;
Noris, Marina .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) :454-464
[10]
IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura [J].
Ferrari, S. ;
Mudde, G. C. ;
Rieger, M. ;
Veyradier, A. ;
Hovinga, J. A. Kremer ;
Scheiflinger, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) :1703-1710